This page includes the latest FDA filings for Abbott Molecular1300 E Touhy Avenuedes Plaines Il 60018 Pma Numberp030052 Supplement Numbers028 Date Received02 18 2022 Decision Date03 18 2022 Product Code Nsd Advisory Committee Pathology Supplement Type30 Day Notice Supplement Reason Process Change Manufacturer Sterilizer Packager Supplier Expedited Review Granted No. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
ABBOTT MOLECULAR1300 E. Touhy Avenuedes Plaines, IL 60018 PMA NumberP030052 Supplement NumberS028 Date Received02/18/2022 Decision Date03/18/2022 Product Code NSD Advisory Committee Pathology Supplement Type30-day Notice Supplement Reason Process Change - Manufacturer/sterilizer/packager/supplier Expedited Review Granted? No
|UroVysion Bladder Cancer Kit||2022-03-18|